Soberlink - MAP Outcomes Study Protocol

N/ATerminatedNCT03190356

Soberlink Healthcare LLC6 enrolled

Overview

The purpose of this study is to show the effectiveness of Soberlink's remote alcohol monitoring system integrated with MAP's patient engagement platform (EHR) to monitor a sample size of at-risk alcohol use disorder (AUD) population. Ultimately, this data is leveraged to improve clinical outcomes and manage financial risk through facilitating early interventions and other means of mitigating recidivism and costly treatment episodes from AUD population.

The study will include 30 Clients with a primary or secondary diagnosis of alcohol use disorder (AUD) and are enrolled in MAP's System where dedicated Case Managers are monitoring the Client's relapse risk levels. Soberlink's remote alcohol system will provide data to inform the Case Manager if the Client has relapsed or is at risk of relapsing through the use of testing data compiled by the Soberlink System. Integrating Soberlink results into MAP's EMR will allow Case Manager to make better clinical decisions and reduce costs by mitigating the chances recidivism through early intervention. Clients will use the Soberlink Device for a period of 90 days.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Alcohol Addiction

Interventions

Soberlink Cellular DeviceDEVICE

Soberlink Cellular Device delivers real-time blood alcohol results to people who support individuals in recovery. MAP platform helps monitor and support compliance with discharge plans while providing tools to improve outcomes for behavioral health diagnoses.

Eligibility

Sex: ALLMin age: 21 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female subject between ages of 21-65 years old * Subject is active in MAP's program with recovery support services * Subject has received acute professional treatment in the last 120 days * Primary or secondary diagnosis is Alcohol Use Disorder * Subject willing to use Soberlink Device to provide BAC * Subject is willing to discuss Soberlink test results with case manager * Subject is willing to sign a Soberlink Client Agreement * Subject is English speaking and reading Exclusion Criteria: * Alcohol Use Disorder is not a primary or secondary diagnosis * Subject is currently taking anti-alcohol medications * Subject will not be in the United States through duration of study * Subject is unwilling to properly use the device * Subject is non-English speaking and reading * Subject is a child, adolescent, cognitively impaired, diagnosed with a mental disorder, such as schizophrenia

Locations (1)

MAP Health Management LLC

Austin, Texas, United States

Outcomes

Primary Outcomes

Recidivism

Determination of client relapse or risk of relapsing through the use of testing data compiled by the Soberlink Cellular Device

Time frame: 90 days duration of subject participation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.